➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Express Scripts
Boehringer Ingelheim
Dow
Medtronic

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Desvenlafaxine fumarate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for desvenlafaxine fumarate and what is the scope of freedom to operate?

Desvenlafaxine fumarate is the generic ingredient in one branded drug marketed by Sun Pharma Global and Teva Pharms Usa, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for desvenlafaxine fumarate.

Summary for desvenlafaxine fumarate
US Patents:0
Tradenames:1
Applicants:2
NDAs:2
Drug Master File Entries: 16
Bulk Api Vendors: 1
Patent Applications: 12
DailyMed Link:desvenlafaxine fumarate at DailyMed

US Patents and Regulatory Information for desvenlafaxine fumarate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global DESVENLAFAXINE desvenlafaxine fumarate TABLET, EXTENDED RELEASE;ORAL 205583-002 Jan 28, 2014 DISCN Yes No   Start Trial   Start Trial   Start Trial
Sun Pharma Global DESVENLAFAXINE desvenlafaxine fumarate TABLET, EXTENDED RELEASE;ORAL 205583-001 Jan 28, 2014 DISCN Yes No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa DESVENLAFAXINE desvenlafaxine fumarate TABLET, EXTENDED RELEASE;ORAL 205208-002 Oct 11, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa DESVENLAFAXINE desvenlafaxine fumarate TABLET, EXTENDED RELEASE;ORAL 205208-001 Oct 11, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
Express Scripts
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.